Alumis (ALMS) Non-Current Assets (2023 - 2025)
Alumis' (ALMS) quarterly Non-Current Assets came in at $93.7 million in Q4 2025, up 169.24% year-on-year from $34.8 million in Q4 2024, and down 1.07% on a QoQ basis from $94.7 million in Q3 2025.
Alumis (ALMS) Non-Current Assets (2023 - 2025) Analysis & Trends
Alumis (ALMS) has 3 years of Non-Current Assets data on file, last reported at $93.7 million in Q4 2025.
- On a quarterly basis, Non-Current Assets rose 169.24% year-over-year to $93.7 million in Q4 2025; TTM through Dec 2025 was $317.6 million, a 116.63% increase from a year earlier, with the FY2025 full-year figure at $93.7 million, up 169.24% from the prior year.
- Non-Current Assets for Q4 2025 stood at $93.7 million, down from $94.7 million in the prior quarter.
- Over the last five years, Non-Current Assets for ALMS reached as high as $94.7 million in Q3 2025 and fell as low as $34.8 million in Q4 2024.
- Historically, Non-Current Assets has averaged $58.0 million across 3 years, with a median of $38.3 million in 2023.
- Across the five-year window, Non-Current Assets decreased 4.0% in 2024 and surged 169.24% in 2025, its largest moves.
- Year by year, Non-Current Assets stood at $36.3 million in 2023, then declined by 4.0% to $34.8 million in 2024, then jumped by 169.24% to $93.7 million in 2025.
- Per Business Quant data, the three most recent Non-Current Assets figures were $93.7 million in Q4 2025, $94.7 million in Q3 2025, and $93.4 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 21.65 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 5.83 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1.95 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 3.95 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 14.75 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.66 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 289.41 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.96 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 285.82 Mn |
| 10 | Alumis | 2.41 Bn | 2.10 Bn | - | 93.71 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 93.71 Mn |
| Sep 30, 2025 | 94.72 Mn |
| Jun 30, 2025 | 93.37 Mn |
| Mar 31, 2025 | 35.77 Mn |
| Dec 31, 2024 | 34.80 Mn |
| Sep 30, 2024 | 35.21 Mn |
| Jun 30, 2024 | 40.32 Mn |
| Dec 31, 2023 | 36.26 Mn |